New drug combo takes on Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase trial tests an experimental drug called BSI-082, alone or combined with a standard cancer drug (T-DXd), in 57 adults with advanced or metastatic solid tumors that have not responded to other treatments. The study has two parts: first, finding the safest dose of B…
Phase: PHASE1 • Sponsor: Lei Zheng • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC